For instance, in the study by Basseres et al. (17), 24.2% (42/173) of non-small cell lung cancers had a HNF3β deletion and in 55.4% (96/173) of these tumors low HNF3β expression was observed. Here, FOXA2 is linked to non-small cell lung carcinoma.